Alden Smith

450 total citations
26 papers, 222 citations indexed

About

Alden Smith is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Alden Smith has authored 26 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nephrology. Recurrent topics in Alden Smith's work include Thyroid and Parathyroid Surgery (13 papers), Parathyroid Disorders and Treatments (7 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Alden Smith is often cited by papers focused on Thyroid and Parathyroid Surgery (13 papers), Parathyroid Disorders and Treatments (7 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Alden Smith collaborates with scholars based in United States, Denmark and Germany. Alden Smith's co-authors include Meryl Brod, David Karpf, Dorthe Viuff, Kathryn M. Pfeiffer, Jill Gianettoni, Aimee D Shu, Mishaela R. Rubin, Andrea Palermo, Susanne Pihl and Aliya Khan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Quality of Life Research.

In The Last Decade

Alden Smith

20 papers receiving 211 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alden Smith 127 94 81 70 25 26 222
Aimee D Shu 118 0.9× 83 0.9× 129 1.6× 33 0.5× 37 1.5× 22 244
М. Б. Анциферов 73 0.6× 30 0.3× 164 2.0× 46 0.7× 41 1.6× 77 272
Karel Dandurand 124 1.0× 118 1.3× 54 0.7× 25 0.4× 13 0.5× 14 205
Loredana Marcovecchio 97 0.8× 45 0.5× 196 2.4× 125 1.8× 14 0.6× 2 253
Ling Ling Chuah 144 1.1× 48 0.5× 93 1.1× 12 0.2× 24 1.0× 13 216
M. Sorger 137 1.1× 13 0.1× 118 1.5× 68 1.0× 32 1.3× 32 302
Mélika Chihaoui 52 0.4× 13 0.1× 147 1.8× 40 0.6× 30 1.2× 93 260
Davide Martinetti 26 0.2× 60 0.6× 24 0.3× 20 0.3× 15 0.6× 5 153
J. Morera 109 0.9× 65 0.7× 125 1.5× 38 0.5× 4 0.2× 28 257
Juliana Austin 87 0.7× 11 0.1× 171 2.1× 84 1.2× 29 1.2× 11 226

Countries citing papers authored by Alden Smith

Since Specialization
Citations

This map shows the geographic impact of Alden Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alden Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alden Smith more than expected).

Fields of papers citing papers by Alden Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alden Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alden Smith. The network helps show where Alden Smith may publish in the future.

Co-authorship network of co-authors of Alden Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Alden Smith. A scholar is included among the top collaborators of Alden Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alden Smith. Alden Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sibley, Christopher T., et al.. (2025). Economic Burden of Postsurgical Chronic Hypoparathyroidism: A US Medicare Claims Retrospective Analysis. Advances in Therapy. 42(10). 4881–4903. 1 indexed citations
2.
Hoffman, Andrew R., Janna Manjelievskaia, Jennifer Cheng, et al.. (2025). Economic burden of growth hormone deficiency among adults who are at risk for and who have confirmed growth hormone deficiency using US real-world data. Journal of Medical Economics. 28(1). 1322–1333.
3.
4.
Hoffman, Andrew R., Janna Manjelievskaia, Jennifer Cheng, et al.. (2025). Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone Deficiency. Advances in Therapy. 42(6). 2853–2873. 2 indexed citations
5.
Albers, Norbert, Benjamin G. Feakins, María Arregui, et al.. (2025). Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency. Journal of the Endocrine Society. 9(5). bvaf040–bvaf040. 1 indexed citations
6.
Savarirayan, Ravi, Ciara McDonnell, Carlos A. Bacino, et al.. (2025). Once-Weekly Navepegritide in Children With Achondroplasia. JAMA Pediatrics. 180(1). 18–18.
7.
Brod, Meryl, et al.. (2024). Measuring treatment impacts on symptoms in adults with hypoparathyroidism: findings from the PaTHway trial. Journal of Patient-Reported Outcomes. 8(1). 94–94.
8.
Clarke, B.L., Aliya Khan, Mishaela R. Rubin, et al.. (2024). Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. The Journal of Clinical Endocrinology & Metabolism. 110(4). 951–960. 11 indexed citations
9.
Smith, Alden, et al.. (2022). PMON64 Economic Burden of Growth Hormone Deficiency in a US Adult Population. Journal of the Endocrine Society. 6(Supplement_1). A559–A560. 1 indexed citations
10.
Pfeiffer, Kathryn M., et al.. (2021). A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being. Orphanet Journal of Rare Diseases. 16(1). 351–351. 6 indexed citations
11.
Khan, Aliya, Lars Rejnmark, Mishaela R. Rubin, et al.. (2021). PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 107(1). e372–e385. 28 indexed citations
12.
Brod, Meryl, Lori McLeod, Denka Markova, et al.. (2021). Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES). Journal of Patient-Reported Outcomes. 5(1). 70–70. 10 indexed citations
13.
Pfeiffer, Kathryn M., et al.. (2021). Functioning and well‐being in older children and adolescents with achondroplasia: A qualitative study. American Journal of Medical Genetics Part A. 188(2). 454–462. 20 indexed citations
14.
Pfeiffer, Kathryn M., et al.. (2020). Assessing the impacts of having a child with achondroplasia on parent well-being. Quality of Life Research. 30(1). 203–215. 11 indexed citations
15.
Brod, Meryl, et al.. (2020). Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact). Quality of Life Research. 30(1). 277–291. 12 indexed citations
16.
Pfeiffer, Kathryn M., et al.. (2020). Correction to: Assessing the impacts of having a child with achondroplasia on parent well-being. Quality of Life Research. 30(1). 217–219. 1 indexed citations
17.
Khan, Aliya, Mishaela R. Rubin, Peter Schwarz, et al.. (2020). Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. Journal of Bone and Mineral Research. 38(1). 14–25. 47 indexed citations
18.
Karpf, David, Chelsea Catsburg, & Alden Smith. (2020). Prevalence of hypoparathyroidism in the EU: A systematic review and meta-analysis. Endocrine Abstracts.
19.
20.
Smith, Alden, Michelle P. McIntosh, GT McInnes, & David H. Lawson. (1986). Trends in psychotropic prescribing in general practice and general medical patients. Postgraduate Medical Journal. 62(729). 637–641. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aimee D Shu Breakdown of academic impact, for papers by М. Б. Анциферов Breakdown of academic impact, for papers by Karel Dandurand Breakdown of academic impact, for papers by Loredana Marcovecchio Breakdown of academic impact, for papers by Ling Ling Chuah Breakdown of academic impact, for papers by M. Sorger Breakdown of academic impact, for papers by Mélika Chihaoui Breakdown of academic impact, for papers by Davide Martinetti Breakdown of academic impact, for papers by J. Morera Breakdown of academic impact, for papers by Juliana Austin
Rankless by CCL
2026